(LRN) Stride - Ratings and Ratios
Online Curricula, School Systems, Career Programs, Adult Training
LRN EPS (Earnings per Share)
LRN Revenue
Description: LRN Stride
Stride Inc (NYSE:LRN) is a technology-driven education company providing online curriculum, software, and services to clients globally, enabling personalized learning for students. The company offers a comprehensive suite of products and services, including virtual and blended public schools, online courses, and supplemental educational materials, primarily targeting kindergarten through twelfth-grade students.
Strides product portfolio extends to career learning programs for adults, focusing on in-demand skills in fields like software engineering, healthcare, and business, under brands such as Galvanize, Tech Elevator, and MedCerts. This diversification into post-secondary education and corporate training services positions the company for growth beyond traditional K-12 markets.
From a financial perspective, Strides market capitalization stands at approximately $5.8 billion, with a forward P/E ratio of 17.51, indicating moderate valuation relative to expected earnings growth. The companys return on equity (RoE) of 23.36% suggests strong profitability. To further evaluate Strides performance, key performance indicators (KPIs) such as revenue growth rate, customer acquisition cost, and student enrollment numbers could provide valuable insights into its operational efficiency and growth prospects.
Additional KPIs to monitor include the average revenue per user (ARPU), gross margin percentage, and operating cash flow margin. These metrics can help assess Strides ability to generate revenue from its diverse product offerings, maintain profitability, and invest in growth initiatives. By analyzing these KPIs in conjunction with the companys financial statements and industry trends, investors can form a more comprehensive view of Strides investment potential.
LRN Stock Overview
| Market Cap in USD | 7,078m |
| Sub-Industry | Education Services |
| IPO / Inception | 2007-12-13 |
LRN Stock Ratings
| Growth Rating | 95.1% |
| Fundamental | 88.6% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 41.5% |
| Analyst Rating | 4.17 of 5 |
LRN Dividends
Currently no dividends paidLRN Growth Ratios
| Growth Correlation 3m | 54.4% |
| Growth Correlation 12m | 87% |
| Growth Correlation 5y | 95.9% |
| CAGR 5y | 50.70% |
| CAGR/Max DD 3y | 1.54 |
| CAGR/Mean DD 3y | 9.63 |
| Sharpe Ratio 12m | 0.44 |
| Alpha | 0.10 |
| Beta | 0.119 |
| Volatility | 37.45% |
| Current Volume | 1585.9k |
| Average Volume 20d | 547.3k |
| Stop Loss | 133.5 (-4.2%) |
| Signal | -0.77 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (287.9m TTM) > 0 and > 6% of Revenue (6% = 144.3m TTM) |
| FCFTA 0.17 (>2.0%) and ΔFCFTA 5.39pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 55.29% (prev 49.08%; Δ 6.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.19 (>3.0%) and CFO 432.8m > Net Income 287.9m (YES >=105%, WARN >=100%) |
| Net Debt (-232.7m) to EBITDA (508.4m) ratio: -0.46 <= 3.0 (WARN <= 3.5) |
| Current Ratio 5.39 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (49.8m) change vs 12m ago 12.47% (target <= -2.0% for YES) |
| Gross Margin 39.24% (prev 37.43%; Δ 1.81pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 114.1% (prev 106.2%; Δ 7.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 37.48 (EBITDA TTM 508.4m / Interest Expense TTM 10.5m) >= 6 (WARN >= 3) |
Altman Z'' 7.35
| (A) 0.58 = (Total Current Assets 1.63b - Total Current Liabilities 302.9m) / Total Assets 2.29b |
| (B) 0.37 = Retained Earnings (Balance) 846.5m / Total Assets 2.29b |
| (C) 0.19 = EBIT TTM 393.7m / Avg Total Assets 2.11b |
| (D) 1.04 = Book Value of Equity 846.4m / Total Liabilities 814.3m |
| Total Rating: 7.35 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 88.59
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 6.11% = 3.06 |
| 3. FCF Margin 16.68% = 4.17 |
| 4. Debt/Equity 0.32 = 2.45 |
| 5. Debt/Ebitda 0.92 = 1.87 |
| 6. ROIC - WACC (= 10.74)% = 12.50 |
| 7. RoE 21.21% = 1.77 |
| 8. Rev. Trend 98.36% = 7.38 |
| 9. EPS Trend 67.99% = 3.40 |
What is the price of LRN shares?
Over the past week, the price has changed by -16.13%, over one month by -14.34%, over three months by -3.05% and over the past year by +68.05%.
Is Stride a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of LRN is around 192.58 USD . This means that LRN is currently undervalued and has a potential upside of +38.24% (Margin of Safety).
Is LRN a buy, sell or hold?
- Strong Buy: 2
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LRN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 163.8 | 17.5% |
| Analysts Target Price | 163.8 | 17.5% |
| ValueRay Target Price | 209.7 | 50.5% |
Last update: 2025-09-06 05:03
LRN Fundamental Data Overview
CCE Cash And Equivalents = 985.3m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 26.8609
P/E Forward = 19.084
P/S = 2.9427
P/B = 4.7112
P/EG = 0.9533
Beta = 0.225
Revenue TTM = 2.41b USD
EBIT TTM = 393.7m USD
EBITDA TTM = 508.4m USD
Long Term Debt = 416.3m USD (from longTermDebt, last quarter)
Short Term Debt = 53.7m USD (from shortTermDebt, last quarter)
Debt = 470.0m USD (Calculated: Short Term 53.7m + Long Term 416.3m)
Net Debt = -232.7m USD (from netDebt column, last quarter)
Enterprise Value = 6.56b USD (7.08b + Debt 470.0m - CCE 985.3m)
Interest Coverage Ratio = 37.48 (Ebit TTM 393.7m / Interest Expense TTM 10.5m)
FCF Yield = 6.11% (FCF TTM 401.1m / Enterprise Value 6.56b)
FCF Margin = 16.68% (FCF TTM 401.1m / Revenue TTM 2.41b)
Net Margin = 11.97% (Net Income TTM 287.9m / Revenue TTM 2.41b)
Gross Margin = 39.24% ((Revenue TTM 2.41b - Cost of Revenue TTM 1.46b) / Revenue TTM)
Tobins Q-Ratio = 7.75 (Enterprise Value 6.56b / Book Value Of Equity 846.4m)
Interest Expense / Debt = 0.57% (Interest Expense 2.69m / Debt 470.0m)
Taxrate = 24.27% (93.0m / 383.2m)
NOPAT = 298.2m (EBIT 393.7m * (1 - 24.27%))
Current Ratio = 5.39 (Total Current Assets 1.63b / Total Current Liabilities 302.9m)
Debt / Equity = 0.32 (Debt 470.0m / last Quarter total Stockholder Equity 1.48b)
Debt / EBITDA = 0.92 (Net Debt -232.7m / EBITDA 508.4m)
Debt / FCF = 1.17 (Debt 470.0m / FCF TTM 401.1m)
Total Stockholder Equity = 1.36b (last 4 quarters mean)
RoA = 12.55% (Net Income 287.9m, Total Assets 2.29b )
RoE = 21.21% (Net Income TTM 287.9m / Total Stockholder Equity 1.36b)
RoCE = 22.20% (Ebit 393.7m / (Equity 1.36b + L.T.Debt 416.3m))
RoIC = 16.82% (NOPAT 298.2m / Invested Capital 1.77b)
WACC = 6.08% (E(7.08b)/V(7.55b) * Re(6.45%)) + (D(470.0m)/V(7.55b) * Rd(0.57%) * (1-Tc(0.24)))
Shares Correlation 3-Years: 96.97 | Cagr: 1.54%
Discount Rate = 6.45% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈333.5m ; Y1≈411.5m ; Y5≈702.0m
Fair Price DCF = 273.7 (DCF Value 11.94b / Shares Outstanding 43.6m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 67.99 | EPS CAGR: 206.7% | SUE: 1.49 | # QB: 1
Revenue Correlation: 98.36 | Revenue CAGR: 16.93% | SUE: N/A | # QB: None
Additional Sources for LRN Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle